DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 146 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2020. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,945,921 | +6.0% | 199,453 | -7.3% | 0.00% | 0.0% |
| Q2 2023 | $2,779,428 | +48.3% | 215,126 | +12.6% | 0.00% | +50.0% |
| Q1 2023 | $1,874,407 | -3.6% | 191,071 | +4.6% | 0.00% | 0.0% |
| Q4 2022 | $1,943,981 | +16.5% | 182,705 | +14.3% | 0.00% | 0.0% |
| Q3 2022 | $1,669,000 | -18.5% | 159,892 | -1.7% | 0.00% | 0.0% |
| Q2 2022 | $2,048,000 | +5.1% | 162,660 | -9.5% | 0.00% | 0.0% |
| Q1 2022 | $1,948,000 | -10.8% | 179,729 | +15.8% | 0.00% | +100.0% |
| Q4 2021 | $2,183,000 | -25.1% | 155,182 | +2.3% | 0.00% | -50.0% |
| Q3 2021 | $2,915,000 | +107.2% | 151,689 | +6.1% | 0.00% | +100.0% |
| Q2 2021 | $1,407,000 | +34.9% | 142,911 | +34.6% | 0.00% | 0.0% |
| Q1 2021 | $1,043,000 | -29.7% | 106,198 | -68.1% | 0.00% | 0.0% |
| Q4 2020 | $1,484,000 | -34.1% | 333,319 | -36.1% | 0.00% | 0.0% |
| Q3 2020 | $2,251,000 | +2.9% | 521,221 | +111.3% | 0.00% | -50.0% |
| Q2 2020 | $2,188,000 | +481.9% | 246,701 | +131.4% | 0.00% | – |
| Q1 2020 | $376,000 | -46.0% | 106,611 | -12.3% | 0.00% | -100.0% |
| Q4 2019 | $696,000 | +272.2% | 121,533 | +131.0% | 0.00% | – |
| Q3 2019 | $187,000 | +6.2% | 52,613 | +18.7% | 0.00% | – |
| Q2 2019 | $176,000 | -91.7% | 44,336 | -84.7% | 0.00% | -100.0% |
| Q1 2019 | $2,126,000 | +97.6% | 290,648 | +147.3% | 0.00% | +100.0% |
| Q4 2018 | $1,076,000 | +238.4% | 117,523 | +359.0% | 0.00% | – |
| Q3 2018 | $318,000 | -83.4% | 25,605 | -79.6% | 0.00% | -100.0% |
| Q2 2018 | $1,917,000 | -25.9% | 125,653 | -3.7% | 0.00% | 0.0% |
| Q1 2018 | $2,588,000 | +60.5% | 130,423 | +51.3% | 0.00% | +100.0% |
| Q4 2017 | $1,612,000 | -65.0% | 86,190 | -59.8% | 0.00% | -75.0% |
| Q3 2017 | $4,610,000 | +919.9% | 214,428 | +357.0% | 0.00% | – |
| Q2 2017 | $452,000 | +120.5% | 46,922 | +36.0% | 0.00% | – |
| Q1 2017 | $205,000 | -23.8% | 34,499 | -49.5% | 0.00% | – |
| Q4 2016 | $269,000 | -53.5% | 68,345 | +23.8% | 0.00% | -100.0% |
| Q3 2016 | $579,000 | +18.2% | 55,220 | +64.4% | 0.00% | 0.0% |
| Q2 2016 | $490,000 | -60.1% | 33,597 | -47.4% | 0.00% | 0.0% |
| Q1 2016 | $1,228,000 | +45.2% | 63,882 | +82.6% | 0.00% | 0.0% |
| Q4 2015 | $846,000 | +41.7% | 34,987 | +43.7% | 0.00% | 0.0% |
| Q3 2015 | $597,000 | -42.4% | 24,343 | -45.1% | 0.00% | 0.0% |
| Q2 2015 | $1,037,000 | +43.4% | 44,310 | +37.4% | 0.00% | 0.0% |
| Q1 2015 | $723,000 | -5.0% | 32,245 | -28.5% | 0.00% | 0.0% |
| Q4 2014 | $761,000 | – | 45,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |